3QW-26627-50089
2 vaccinations
3 coded responses
11 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 241 / VA
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Dose 1 — Pfizer-BioNTech
-
2021-01-18
Registered in v-safe
- 2021-01-18
- 2021-01-25
-
2021-02-01
Dose 2 — Pfizer-BioNTech
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-09
- 2021-03-15
-
2021-05-03
Survey response — 3 months, dose 2MedDRA: Back pain, Chills, Fatigue, Headache, Injection site rash, Nausea, Office visit, Pain, Pyrexia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Received TDAP vaccine 4/27 at PCP office as part of physical; developed low grade fever, chills, nausea, headache, rash on upper arm of injection site and back, back pain and generalized aching along with extreme fatigue. Symptoms lasted 3-4 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-04
Survey response — 6 months, dose 2MedDRA: Adverse reaction, Cough, Discharge, Headache, Paranasal sinus discomfort, SARS-CoV-2 test, Sinus disorder — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Allergy/sinus symptoms - drainage, dry cough, sinus pressure, headache · Healthcare visit (other): Covid PCR test 8/4MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-04
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-11-22
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-02-01
Survey response — 12 months, dose 2MedDRA: Chills, Cough, Headache, Pain, Pyrexia, SARS-CoV-2 test positive — Feeling: GoodFree text: Body aches, Headache, Fever/Chills, Cough Positive COVID Test 1/12/22MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Pfizer-BioNTech | |
| 2 | 2021-02-01 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 8 — 3 months, dose 2
Symptoms: Received TDAP vaccine 4/27 at PCP office as part of physical; developed low grade fever, chills, nausea, headache, rash on upper arm of injection site and back, back pain and generalized aching along with extreme fatigue. Symptoms lasted 3-4 days
Release 9 — 6 months, dose 2
Symptoms: Allergy/sinus symptoms - drainage, dry cough, sinus pressure, headache
Healthcare visit (other): Covid PCR test 8/4
Release 11 — 12 months, dose 2
Symptoms: Body aches, Headache, Fever/Chills, Cough Positive COVID Test 1/12/22
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test | ✓ | · | ✓ |
| SD | Adverse reaction | ✓ | · | ✓ |
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Discharge | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Office visit | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Paranasal sinus discomfort | ✓ | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinus disorder | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release